Specialist in Emerging Markets Health Care
Successful investment track record.
Structured approach using bespoke evaluation tools.
Comprehensive assessment of market and business operations.
High degree of reassurance, supported by evidence-based analysis and conclusions.
Across the globe spending on health care continues to grow strongly - driven by rapidly aging populations, availability of new technologies, and rising incomes and expectations. Nowhere is this more evident than in emerging markets. As a result, the health sector offers potentially very attractive investment, and social, returns – evidenced, in recent years, by scores of listings and the emergence of several international health care companies.
We specialize in support to all phases of the investment/M&A project cycle including:
initial project identification and screening
due diligence and feasibility analysis
performance improvement and turnaround
business strategy formulation and execution
Refined and tested over several years we have developed a robust process for due diligence assessment which encompasses:
governance and management
performance (including financial, utilization and efficiency)
performance improvement potential
risk assessment (including business, clinical, environmental, insurance)